| scholarly article | Q13442814 |
| P2093 | author name string | Stephen Lyle | |
| JeanMarie Houghton | |||
| Nathan Moore | |||
| P2860 | cites work | Efficient tumour formation by single human melanoma cells | Q24648938 |
| CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors | Q24652007 | ||
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| Identification and expansion of human colon-cancer-initiating cells | Q27860627 | ||
| The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status | Q28142436 | ||
| Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content | Q28270471 | ||
| Generation of a functional mammary gland from a single stem cell | Q29616496 | ||
| Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population | Q33183624 | ||
| Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance | Q33567293 | ||
| Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial | Q34607843 | ||
| Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy | Q36678657 | ||
| Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells | Q36787387 | ||
| Direct cellular responses to platinum-induced DNA damage | Q36800400 | ||
| Regeneration of intestinal stem/progenitor cells following doxorubicin treatment of mice | Q37337711 | ||
| Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma | Q37418677 | ||
| Resistance to apoptosis-inducing stimuli in CD44+ head and neck squamous cell carcinoma cells | Q39562499 | ||
| A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth | Q39703155 | ||
| Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy | Q39768597 | ||
| Stem cells in gastrointestinal epithelium: numbers, characteristics and death | Q40849001 | ||
| CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. | Q48289389 | ||
| Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy. | Q53846240 | ||
| Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells | Q72769766 | ||
| Hematopoietic stem cell quiescence maintained by p21cip1/waf1 | Q73532192 | ||
| Residual risk of breast cancer recurrence 5 years after adjuvant therapy | Q81769695 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1822-1830 | |
| P577 | publication date | 2011-11-11 | |
| P1433 | published in | Stem Cells and Development | Q15724421 |
| P1476 | title | Slow-cycling therapy-resistant cancer cells | |
| P478 | volume | 21 |
| Q38743865 | ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment |
| Q36884873 | ATR Kinase Inhibition Protects Non-cycling Cells from the Lethal Effects of DNA Damage and Transcription Stress |
| Q37700932 | Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway |
| Q97570276 | Cancer Cell enters reversible quiescence through Intracellular Acidification to resist Paclitaxel Cytotoxicity |
| Q92703787 | Cancer Stem Cells and Targeting Strategies |
| Q36730432 | Cancer stem cells and chemoresistance: The smartest survives the raid |
| Q46082551 | Characterization and functional analysis of a slow-cycling subpopulation in colorectal cancer enriched by cell cycle inducer combined chemotherapy |
| Q37708921 | Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface |
| Q58094206 | Chemotherapy resistance and stemness in mitotically quiescent human breast cancer cells identified by fluorescent dye retention |
| Q90365564 | Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme |
| Q48148598 | Developmentally regulated signaling pathways in glioma invasion. |
| Q35807620 | Differential Sensitivities of Fast- and Slow-cycling Cancer Cells to Inosine Monophosphate Dehydrogenase 2 Inhibition by Mycophenolic Acid. |
| Q28082935 | EMT, CTCs and CSCs in tumor relapse and drug-resistance |
| Q27321048 | Estimating dose painting effects in radiotherapy: a mathematical model |
| Q46581912 | Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors |
| Q41916016 | Immunotherapy for lung cancer |
| Q57462296 | Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma |
| Q37718357 | Intracellular STING inactivation sensitizes breast cancer cells to genotoxic agents |
| Q35994416 | Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition |
| Q99414140 | Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition |
| Q55421215 | Itraconazole targets cell cycle heterogeneity in colorectal cancer. |
| Q37106630 | Label-retaining assay enriches tumor-initiating cells in glioblastoma spheres cultivated in serum-free medium |
| Q90667583 | Loss of PDPK1 abrogates resistance to gemcitabine in label-retaining pancreatic cancer cells |
| Q92488177 | Mathematical modelling reveals unexpected inheritance and variability patterns of cell cycle parameters in mammalian cells |
| Q38559618 | Mechanisms of Metastatic Tumor Dormancy |
| Q55424318 | Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance. |
| Q28539003 | Model of tumor dormancy/recurrence after short-term chemotherapy |
| Q92133904 | Modulation of proliferation factors in lung adenocarcinoma with an analysis of the transcriptional consequences of genomic EGFR activation |
| Q38831002 | New ex-ovo colorectal-cancer models from different SdFFF-sorted tumor-initiating cells. |
| Q42356676 | Overexpression of the scaffold WD40 protein WRAP53β enhances the repair of and cell survival from DNA double-strand breaks |
| Q61818028 | Single cell functional genomics reveals the importance of mitochondria in cell-to-cell phenotypic variation |
| Q46514101 | Single-cell RNA sequencing reveals intrinsic and extrinsic regulatory heterogeneity in yeast responding to stress. |
| Q38218129 | Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer. |
| Q47554623 | Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies |
| Q38041726 | Stem-like cells and therapy resistance in squamous cell carcinomas |
| Q47236781 | The depalmitoylase APT1 directs the asymmetric partitioning of Notch and Wnt signaling during cell division |
| Q64263344 | The impact of proliferation-migration tradeoffs on phenotypic evolution in cancer |
| Q47423338 | Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line. |
| Q21195742 | Tumor dormancy: potential therapeutic target in tumor recurrence and metastasis prevention |
| Q38891175 | Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines |
Search more.